Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PPAR-delta as a Novel Therapeutic Target in Asthma
Transgenic Animal Core
Programs of Excellence in Molecular Biology
Fatalities From Innumotherapy and Skin Testing with Allergenic Extracts
DMSS: Network Coding Techniques for Scalable Distributed Media Storage and Streaming
Recently added grants:
Investigating the requirement of MRAP2 for ghrelin function
Role of Brown Adipose Tissue Thermogenesis in Oxytocin-Elicited Weight Loss
Effects of Iron Deficiency, Inflammation, and Kidney Clearance on Circulating Fibroblast Growth Factor-23 Concentrations
Impact of Aspirin on the Gut Microbiome and Mucosal Microenvironment
Mentored Education for Dissemination and Implementation Science (MEDIS) Program
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07160-32-0-1
Application #
7575499
Study Section
Project Start
2000-08-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Clinical Trials and Surveys Corporation
$1,684,146
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial - Mcc
Thompson, Bruce W. /
$250,000
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant